SAT1 and glioblastoma multiforme: Disarming the resistance

Adina Brett-Morris; Mazen Mislmani; Scott M. Welford

doi:10.4161/23723556.2014.983393

SAT1 and glioblastoma multiforme: Disarming the resistance

Adina Brett-Morris, Mazen Mislmani, Scott M. Welford

Radiation Oncology

Research output: Contribution to journal › Article

1 Scopus citations

Abstract

Glioblastoma multiforme is the most common and most detrimental form of brain tumor, with a current survival time of as little as 14 months. We have recently identified a novel mechanism of therapeutic resistance based on overexpression of the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase, which promotes DNA repair via chromatin modification.

Original language	English (US)
Article number	e983393
Journal	Molecular and Cellular Oncology
Volume	2
Issue number	3
DOIs	https://doi.org/10.4161/23723556.2014.983393
State	Published - Jul 3 2015

Keywords

BRCA1
SAT1
glioblastoma
histone acetylation
radiation resistance

ASJC Scopus subject areas

Molecular Medicine
Cancer Research

Access to Document

10.4161/23723556.2014.983393

Fingerprint Dive into the research topics of 'SAT1 and glioblastoma multiforme: Disarming the resistance'. Together they form a unique fingerprint.

Cite this

Brett-Morris, A., Mislmani, M., & Welford, S. M. (2015). SAT1 and glioblastoma multiforme: Disarming the resistance. Molecular and Cellular Oncology, 2(3), [e983393]. https://doi.org/10.4161/23723556.2014.983393

@article{bbb69a66666f464a89411032a5ff2812,

title = "SAT1 and glioblastoma multiforme: Disarming the resistance",

abstract = "Glioblastoma multiforme is the most common and most detrimental form of brain tumor, with a current survival time of as little as 14 months. We have recently identified a novel mechanism of therapeutic resistance based on overexpression of the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase, which promotes DNA repair via chromatin modification.",

keywords = "BRCA1, SAT1, glioblastoma, histone acetylation, radiation resistance",

author = "Adina Brett-Morris and Mazen Mislmani and Welford, {Scott M.}",

year = "2015",

month = jul,

day = "3",

doi = "10.4161/23723556.2014.983393",

language = "English (US)",

volume = "2",

journal = "Molecular and Cellular Oncology",

issn = "2372-3556",

publisher = "Taylor and Francis Ltd.",

number = "3",

}

TY - JOUR

T1 - SAT1 and glioblastoma multiforme

T2 - Disarming the resistance

AU - Brett-Morris, Adina

AU - Mislmani, Mazen

AU - Welford, Scott M.

PY - 2015/7/3

Y1 - 2015/7/3

N2 - Glioblastoma multiforme is the most common and most detrimental form of brain tumor, with a current survival time of as little as 14 months. We have recently identified a novel mechanism of therapeutic resistance based on overexpression of the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase, which promotes DNA repair via chromatin modification.

AB - Glioblastoma multiforme is the most common and most detrimental form of brain tumor, with a current survival time of as little as 14 months. We have recently identified a novel mechanism of therapeutic resistance based on overexpression of the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase, which promotes DNA repair via chromatin modification.

KW - BRCA1

KW - SAT1

KW - glioblastoma

KW - histone acetylation

KW - radiation resistance

UR - http://www.scopus.com/inward/record.url?scp=85041191955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041191955&partnerID=8YFLogxK

U2 - 10.4161/23723556.2014.983393

DO - 10.4161/23723556.2014.983393

M3 - Article

AN - SCOPUS:85041191955

VL - 2

JO - Molecular and Cellular Oncology

JF - Molecular and Cellular Oncology

SN - 2372-3556

IS - 3

M1 - e983393

ER -